| Neuraxpharm Switzerland AG - Tranxilium 20, Hartkapseln |
| 33866 | | 03 | | Tranxilium 20 | | Hartkapseln | | N05BA05 | | Dikaliumclorazepat | | 18.09.1975 | | |
|
| Composition |
| dikalii clorazepas 20 mg, kalii carbonas, talcum, Kapselhülle: gelatina, E 132, E 171, pro capsula. |
| Packungsbestandteile |
| Capsules | | | | | Principe actif | Concentr. |
|---|
| Clorazepat-Dikalium | 20 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Clorazepat-Dikalium | 20 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| E 132 | | color. | | E 171 | | color. | | Gelatina | | Kapselhülle | | Potassium Carbonate | | | | Pro Capsula | | | | Talcum | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 075 | 20 Gélule(s) | 4.32 | 13.90 | B | LS | Non | | 076 | 50 Gélule(s) | 9.90 | 27.15 | B | LS | Non |
|